Detailed information for compound 106175

Basic information

Technical information
  • TDR Targets ID: 106175
  • Name: 2-[(4-methoxypyrrolo[2,3-d]pyrimidin-7-yl)met hoxy]ethanol
  • MW: 223.229 | Formula: C10H13N3O3
  • H donors: 1 H acceptors: 3 LogP: 0.12 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ncnc2c1ccn2COCCO
  • InChi: 1S/C10H13N3O3/c1-15-10-8-2-3-13(7-16-5-4-14)9(8)11-6-12-10/h2-3,6,14H,4-5,7H2,1H3
  • InChiKey: MYXLXOVCSVHVDO-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[(4-methoxy-7-pyrrolo[2,3-d]pyrimidinyl)methoxy]ethanol
  • 2-[(4-methoxypyrrolo[3,2-e]pyrimidin-7-yl)methoxy]ethanol
  • 2-[(4-methoxy-7-pyrrolo[3,2-e]pyrimidinyl)methoxy]ethanol
  • AIDS-212142
  • AIDS212142
  • Ethanol, 2-[(4-methoxy-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methoxy]-

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis glucosylceramidase, putative 0.2607 1 1
Loa Loa (eye worm) O-glycosyl hydrolase family 30 protein 0.2607 1 1
Echinococcus multilocularis non lysosomal glucosylceramidase 0.2101 0.6662 0.5432
Onchocerca volvulus Ceramide glucosyltransferase homolog 0.2408 0.8687 1
Echinococcus multilocularis bile acid beta glucosidase 0.2101 0.6662 0.5432
Trichomonas vaginalis glucosylceramidase, putative 0.2607 1 1
Loa Loa (eye worm) glycosyl hydrolase family 31 protein 0.1736 0.4254 0.2675
Trichomonas vaginalis glucosylceramidase, putative 0.2607 1 1
Onchocerca volvulus Glucosylceramidase homolog 0.171 0.4084 0.4381
Echinococcus granulosus bile acid beta glucosidase 0.2101 0.6662 0.5432
Trichomonas vaginalis glucosylceramidase, putative 0.2607 1 1
Echinococcus granulosus non lysosomal glucosylceramidase 0.2101 0.6662 0.5432
Trichomonas vaginalis glucosylceramidase, putative 0.2607 1 1
Schistosoma mansoni bile acid beta-glucosidase-related 0.2101 0.6662 0.5432
Echinococcus granulosus ceramide glucosyltransferase 0.2408 0.8687 1
Giardia lamblia Ceramide glucosyltransferase 0.1091 0 0.5
Schistosoma mansoni ceramide glucosyltransferase 0.2408 0.8687 1
Loa Loa (eye worm) ceramide glucosyltransferase 0.2408 0.8687 0.8326
Schistosoma mansoni bile acid beta-glucosidase-related 0.2101 0.6662 0.5432
Brugia malayi Ceramide glucosyltransferase 0.2408 0.8687 0.7714
Trichomonas vaginalis glucosylceramidase, putative 0.1802 0.4692 0.1027
Echinococcus multilocularis ceramide glucosyltransferase 0.2408 0.8687 1
Trichomonas vaginalis glucosylceramidase, putative 0.2607 1 1
Schistosoma mansoni ceramide glucosyltransferase 0.2408 0.8687 1
Trichomonas vaginalis glucosylceramidase, putative 0.1802 0.4692 0.1027

Activities

Activity type Activity value Assay description Source Reference
I50 (functional) > 100 uM Inhibitory concentration against human cytomegalovirus(HCMV) in plaque reduction assay at 100 uM concentration ChEMBL. 2846837
IC50 (functional) > 100 uM Inhibitory concentration against HCMV in plaque reduction assay ChEMBL. 2846837
IC50 (functional) > 100 uM Cytotoxicity against uninfected human foreskin fibroblast(HFF cells) ChEMBL. 2846837
IC50 (functional) > 100 uM Cytotoxicity against uninfected monkey kidney cells (BSC-1) ChEMBL. 2846837
IC50 (functional) > 100 uM Cytotoxicity against uninfected human foreskin fibroblast(HFF cells) ChEMBL. 2846837
Inhibition (functional) = 80 % Cytotoxicity against human neoplastic cell line(KB cells) ChEMBL. 2846837

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.